The city pays great attention to the topic of treatment and maintaining the health of citizens.
Taking this into account, capital companies are actively engaged in the production of medicines.
Over the 11 months of last year, the volume of production of pharmaceuticals in Moscow increased by 47.2% - almost 2 times.
Details are provided by TASS, citing the press service of the Moscow Complex of Economic Policy and Property and Land Relations and Deputy Mayor of Moscow Vladimir Vladimirovich Efimov.
It is noted that currently 95 enterprises in the capital are engaged in the production of medicines.
According to Efimov, the cost of shipped goods from January to November 2023 exceeded the 2022 figures.
It is also known that the capital's enterprises are engaged in the production of drugs for the treatment of diabetes, heart and vascular diseases, and oncology. They also produce immunomodulators and hormonal drugs.
Earlier, it was reported that the number of cases of influenza and acute respiratory viral infections in the Russian Federation had increased over the past week .